bioMérieux S.A.

BMXXY | OTC

Price Alert Chart Builder DCF Calculator

$10.19

$0.00 (0.00%)

Nov 2, 2026, 9:50 AM ET · Market open

Overview Rating Statistics Financials Earnings Ownership Dividends Profile

+0.00%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Oct 10, 2026

+8.5 pts

Fundamentals Strong

Market Sentiment Neutral

Moat Narrow

Full Analysis

Key Statistics

Market Data

Market Cap $11.99B

1D Range

10.10 10.19

52W Range

7.12 14.55

Valuation (TTM)

PE 2.24

PB 2.44

EV/EBITDA 11.19

Valuation (NTM)

Forward PE N/A

Forward PEG -5.56

Price Target $0.00

Cash Flow

FCF Yield 5.5%

SBC Adj. FCF Yield 5.5%

SBC Impact N/A

Margins

Gross Margin 52.0%

Operating Margin 12.0%

FCF Margin 14.7%

Growth (CAGR)

Revenue 3Y | 5Y 11.5% | 14.4%

Dil EPS 3Y | 5Y 14.8% | 27.7%

FCF 3Y | 5Y 39.3% | 40.8%

Returns

ROA 8.1%

ROE 11.0%

ROIC 7.6%

Financial Health

Net Cash

€390.7M ($446.25M)

Current Ratio 2.30

Interest Coverage 57.63

Dividends

Div Yield 1.08%

Payout Ratio 2.9%

FCF Payout Ratio 19.7%

All Key Statistics

Loading financial charts...

Profile

bioMérieux S.A. is a global leader in the development and production of in vitro diagnostic solutions, primarily aimed at detecting infectious diseases. Its operations span the Americas, Europe, the M...

Sector Healthcare

Industry Medical - Diagnostics & Research

Employees 15,078

IPO Date Jun 9, 2023

Website www.biomerieux.com

Fiscal Year n/a

Full Company Profile

Latest News

No news articles available yet.